SriSai Biopharmaceutical Solutions (SBS) has been providing comprehensive support services to the life sciences industry for over 15 years in the areas of supply chain management. These services include storage and global distribution, secondary packaging and labeling, validation and consultation. SBS currently serves clients from both the government and commercial sectors with adherence to Good Laboratory Practices (GLP), Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), Good Documentation Practices (GDP), Food and Drugs Administration (FDA) administration regulations and in accordance with client requirements. These activities are in support of Phase I, and/or II, and/or III clinical studies (Investigational New Drug also known as IND or New Drug Application also known as NDA).
